Daiichi Sankyo’s edoxaban launched in the UK
10 July 2015 | By Victoria White
Edoxaban, a new blood-thinning drug therapy to help prevent stroke in patients with non-valvular atrial fibrillation, has been launched in the UK...
List view / Grid view
News
Lilly issues statement on FDA Advisory Committee review of necitumumab
10 July 2015 | By Victoria White
Lilly has issued a statement in response to the US Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee’s ongoing review of necitumumab...
NICE recommends vedolizumab for severe Crohn’s disease
10 July 2015 | By Victoria White
Vedolizumab, a drug to treat Crohn’s disease, has been recommended for routine NHS funding by the UK's National Institute for Health and Care Excellence...
Fresenius Kabi and Calea sentenced for supplying hospitals with defective pre-filled syringes
10 July 2015 | By Victoria White
Fresenius Kabi and Calea have been sentenced for supplying hospitals with defective pre-filled syringes that contributed to the death of a diabetic patient...
Curo receives the Queen’s Award for Enterprise
9 July 2015 | By Victoria White
Market Access Consultants Curo have received the highest accolade given to British businesses, the Queen’s Award for Enterprise...
Graphene boosts chemotherapy treatment effect
9 July 2015 | By Victoria White
Researchers have been studying what happens when different chemotherapy drugs come in contact with the silver coating on catheters with surprising results...
Tillotts to acquire global rights for Entocort from AstraZeneca outside the US
9 July 2015 | By Victoria White
Tillotts Pharma has entered into an agreement for the acquisition of the global rights for Entocort from AstraZeneca, excluding the US...
Teva first to receive approval and launch generic Axert tablets in the US
9 July 2015 | By Victoria White
Teva has launched generic Axert® (almotriptan malate) tablets in the US for the treatment of migraine attacks in adults and adolescents...
Aridis expands Phase 2a trial of AR-301 into the US
9 July 2015 | By Victoria White
The US Food and Drug Administration (FDA) has accepted Aridis Pharmaceuticals’ Investigational New Drug (IND) application for AR-301 (Salvecin)...
Progesterone could help treat breast cancer
9 July 2015 | By Victoria White
Around half of all breast cancer patients could one day benefit from having the cheap and widely-available hormone progesterone added to their treatment...
Phase 2b findings demonstrate efficacy of guselkumab in treatment of moderate to severe plaque psoriasis
9 July 2015 | By Victoria White
A trial of has shown up to 86% of patients with psoriasis receiving guselkumab achieved a PGA score of cleared psoriasis or minimal psoriasis at week 16...
Sanofi extends collaboration with Medicines for Malaria Venture
8 July 2015 | By Victoria White
Sanofi is to extend its collaboration with Medicines for Malaria Venture (MMV) to jointly develop a new single, fixed-dose combination therapy for malaria...
Arrowhead receives regulatory clearance for ARC-AAT Phase 1 study in the UK and New Zealand
8 July 2015 | By Victoria White
Arrowhead Research Corporation has received regulatory permission in the UK and New Zealand to proceed with Part B of its Phase 1 study of ARC-AAT...
Lilly’s NSCLC drug necitumumab shows risk of blood clots
8 July 2015 | By Victoria White
Lilly’s NSCLC drug, necitumumab, has raised concerns with the FDA after trial data suggested that the drug might increase the likelihood of fatal clots...
AXON Neuroscience’s vaccine designed to halt Alzheimer’s finishes Phase 1 clinical trial
8 July 2015 | By Victoria White
AXON Neuronscience's vaccine intended to be a disease modifying drug for Alzheimer’s disease patients has passed a Phase 1 safety trial...
